Evolution of <scp>CEACAM</scp> pathogen decoy receptors in primates

Abstract Background CEACAM1 in leukocytes controls cell activation during inflammation. This and its expression in epithelial cells led to frequent independent appropriation of CEACAM1 as receptor by pathogens in humans and other species to gain host access and to downregulate its immune response. As a countermeasure, decoy receptors with CEACAM1‐like pathogen‐binding domains evolved. The granulocyte‐specific human CEACAM3 endocytic receptor diverts CEACAM1‐binding pathogens to neutrophils for internalization and destruction. The role of the glycosylphosphatidylinositol‐anchored CEACAM5 and CEACAM6 which can also bind CEACAM1‐targeting pathogens in humans is less clear. Methods We analyzed the selection of CEACAMs to avoid pathogen binding and to maintain similarity between pathogen receptors and decoy receptors in 148 primate species. Results Notably, functional CEACAM3 genes were not found in gibbons and New World monkeys. Interestingly, CEACAM6 in these primates exhibits similar high ratios of rates of nonsynonymous and synonymous substitution (dN/dS) in their pathogen‐binding N domain exons as found for CEACAM1 . High dN/dS ratios are indicative of selection for diversification typically seen in pathogen receptors. Human CEACAM6 is expressed on granulocytes and epithelial cells. Therefore, CEACAM6 could substitute for the missing endocytic receptor CEACAM3. In nearly all investigated primate groups also N exons of the epithelially expressed CEACAM5 exhibit selection for diversification. In African populations, five high‐frequency polymorphisms are observed in the pathogen‐binding region of CEACAM5 (I80V, V83A, I100T, I112V, I113T) with 3‐4 polymorphisms combined in the same individual. These polymorphisms correspond to CEACAM1 pathogen‐binding domain sequences. Conclusion The glycosylphosphatidylinositol‐anchored CEACAM5 and CEACAM6 are under selection to maintain similarity to the pathogen receptor CEACAM1 in most primate species, indicating a function as decoy receptors.

Authors

Institutions

Publication Details

Journal
European Journal of Clinical Investigation
Published
2024-12-01
DOI
https://doi.org/10.1111/eci.14356
Citations
1
Primary Topic
Cell Adhesion Molecules Research
Type
article
Field-Weighted Citation Impact
0.38
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evolution of CEACAM pathogen decoy receptors in primates

Robert Kammerer, Wolfgang Zimmermann
1 citations
European Journal of Clinical Investigation
Cell Adhesion Molecules Research
0.38
article

Evolution of CEACAM pathogen decoy receptors in primates

Robert Kammerer, Wolfgang Zimmermann
article en
1 citations

Abstract

Abstract Background CEACAM1 in leukocytes controls cell activation during inflammation. This and its expression in epithelial cells led to frequent independent appropriation of CEACAM1 as receptor by pathogens in humans and other species to gain host access and to downregulate its immune response. As a countermeasure, decoy receptors with CEACAM1‐like pathogen‐binding domains evolved. The granulocyte‐specific human CEACAM3 endocytic receptor diverts CEACAM1‐binding pathogens to neutrophils for internalization and destruction. The role of the glycosylphosphatidylinositol‐anchored CEACAM5 and CEACAM6 which can also bind CEACAM1‐targeting pathogens in humans is less clear. Methods We analyzed the selection of CEACAMs to avoid pathogen binding and to maintain similarity between pathogen receptors and decoy receptors in 148 primate species. Results Notably, functional CEACAM3 genes were not found in gibbons and New World monkeys. Interestingly, CEACAM6 in these primates exhibits similar high ratios of rates of nonsynonymous and synonymous substitution (dN/dS) in their pathogen‐binding N domain exons as found for CEACAM1 . High dN/dS ratios are indicative of selection for diversification typically seen in pathogen receptors. Human CEACAM6 is expressed on granulocytes and epithelial cells. Therefore, CEACAM6 could substitute for the missing endocytic receptor CEACAM3. In nearly all investigated primate groups also N exons of the epithelially expressed CEACAM5 exhibit selection for diversification. In African populations, five high‐frequency polymorphisms are observed in the pathogen‐binding region of CEACAM5 (I80V, V83A, I100T, I112V, I113T) with 3‐4 polymorphisms combined in the same individual. These polymorphisms correspond to CEACAM1 pathogen‐binding domain sequences. Conclusion The glycosylphosphatidylinositol‐anchored CEACAM5 and CEACAM6 are under selection to maintain similarity to the pathogen receptor CEACAM1 in most primate species, indicating a function as decoy receptors.

European Journal of Clinical InvestigationVol. 54(S2)
Friedrich-Loeffler-Institut (DE), Ludwig-Maximilians-Universität München (DE)
Life in Land
Openalex Percentile: Top 33%
Cell Adhesion Molecules Research
0.38
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.